8 results
Stroke Rate by CHADS2 Score (Gage et al., JAMA, 2001) https://www.ncbi.nlm.nih.gov/pubmed/?term=11401607 #EBM #EM #IM #Cardiology #CHADS2
term=11401607 #EBM ... #EM #IM #Cardiology ... Score #StrokeRate #ALiEM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
A 27-year-old man with a 2-year history of recurrent, painful skin lesions. A diagnosis of hidradenitis
#Clinical #Derm ... #IM #Hidradenitis ... HidradenitisSuppurativa #NEJM
Nephron Remodeling as a Mechanism of Diuretic Resistance. When high doses of loop diuretics are used
used on a long-term ... Pathophysiology #Nephro #IM ... NephronRemodeling #NEJM
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
Antithrombotic Therapy with Dabigatran ... warfarin (Panel A) #EBM ... #Cardiology #IM ... #REDUAL #Dabigatran ... AtrialFibrillation #NEJM
Evolution of Purpura Fulminans - On physical examination, he had small purpura on his legs (Panel
#Clinical #Derm ... #EM #IM #PurpuraFulminans ... Meningococcemia #NEJM